Viatris CEO Scott Smith says the acquisition enables the firm to “strengthen our position in non-opioid pain management” and ...

Teva’s Weltruza was “developed with the patient in mind from day one,” says Chris Fox, Executive VP, as the company advances ...

Danaher CEO Julie Sawyer Montgomery described the planned AI lab as “an important milestone” towards expediting “the journey from discovery to impact” ...

Spencer Stiles, who will assume the CEO position after serving as COO at Stryker since January 2026, describes taking the ...

Jonathon Lawrence, Managing Director UK&I at Fresenius, says the dialysis centre will put “lower-carbon design at the heart ...

CEO Mike Mahoney names Joe Fitzgerald EVP & COO at Boston Scientific as the medtech giant restructures into three clinical ...

Global research by Johnson & Johnson and Ipsos finds vision is overlooked as a menopause symptom, revealing a gap in ...

Novo’s R&D lead Martin Holst Lange says the pill offers an opportunity to “explore more convenient treatment options” for ...

The WHO urges fairer access to GLP‑1 medicines such as Wegovy amid supply and cost pressures, as obesity rates soar and demand outstrips global production With more than one billion people worldwide ...

Eli Lilly CEO David Ricks has announced the company’s Change The Course Commitment, which aims to achieve global diabetes and ...

CEO Brian Tyler will bring McKesson’s “experience and expertise” to support Option Care Health, following a US$5.8bn joint ...

From Oracle to Coupa and SAP to Blue Yonder, Healthcare Digital looks at the leading technological tools and companies ...